Corvus Pharmaceuticals Inc sell StockNews.com
Start price
26.03.23
/
50%
€0.65
Target price
26.03.24
-
Performance (%)
144.58%
End price
27.03.24
€1.58
Summary
This prediction ended on 27.03.24 with a price of €1.58. The price for Corvus Pharmaceuticals Inc massively increased, which is bad news for the SELL prediction by StockNews_com. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Corvus Pharmaceuticals Inc | -6.983% | -6.983% | 185.455% | 438.725% |
| iShares Core DAX® | 3,90 % | 2,67 % | 5,69 % | 53,46 % |
| iShares Nasdaq 100 | -2,60 % | -7,93 % | 19,50 % | 72,28 % |
| iShares Nikkei 225® | -0,54 % | -9,75 % | 46,05 % | 63,08 % |
| iShares S&P 500 | -0,88 % | -1,49 % | 16,91 % | 60,40 % |
Comments by StockNews_com for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CRVS provided by MarketBeat
In the thread Trading Corvus Pharmaceuticals Inc
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€4.55
28.09.24
28.09.24
-
28.09.25
28.09.25
32.97%
29.09.25
29.09.25
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.92
03.04.23
03.04.23
-
03.04.24
03.04.24
81.96%
04.04.24
04.04.24
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.68
18.03.23
18.03.23
-
18.03.24
18.03.24
157.58%
19.03.24
19.03.24